Physician
Lawrence, Karl
Lawrence, Karl was paid $42K by Medicaid between Jan 2019 and Jan 2022, across 12 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 29% of everything it billed.
33Billing provider infoLAWRENCE, KARL
BRISTOL, TN 37620
BRISTOL, TN 37620
33aNPI1033265178assigned 01/25/2007
33bProvider typeInternal Medicine Physician
28Total paid$42K
24GClaims2,288
24DCodes billed12
24AFirst – last monthJan 2019 – Jan 2022
Compared with peers
Next to other Internal Medicine Physician providers in Tennessee
Rank by total paid#210 of 581
Median peer was paid$15K
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 305 | $3K | |
| 2020 | 980 | $23K | |
| 2021 | 973 | $14K | |
| 2022 | 30 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 29% | 559 | 312 | $12K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 27% | 465 | 271 | $11K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 278 | 204 | $5K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.7% | 165 | 121 | $4K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.9% | 309 | 135 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.2% | 203 | 174 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.5% | 90 | 47 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 79 | 50 | $533.05 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 76 | 57 | $265.02 |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | 12 | $17.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17 | 12 | $1.46 |
| 99072 | 0% | 34 | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.